Inventor · disambiguated record
Russell Dahl
Also filed as: DAHL RUSSELL · DAHL RUSSELL S
29 granted patents·13 pending applications·87 citations·filing 2002–2024
95Inventor score
Files withDAHL RUSSELL15NEURODON CORP6ITHERX PHARMACEUTICALS INC4BURNHAM INST MEDICAL RESEARCH3SANFORD BURNHAM MED RES INST3
Top patents by PatentIndex Score
42 records- 0193US11890279B2Quinolines that modulate SERCA and their use for treating diseaseNEURODON CORP·Filed 2023·Granted Feb 6, 2024·1 cites·4 claims
- 0290US10383868B2Quinoline containing compounds and their use for treating endoplasmic reticulum stress-related diseasesDAHL RUSSELL·Filed 2016·Granted Aug 20, 2019·5 cites·3 claims
- 0389US11730729B2Quinolines that modulate SERCA and their use for treating diseaseNEURODON CORP·Filed 2021·Granted Aug 22, 2023·1 cites·4 claims
- 0488US7776894B2Compositions and methods for inhibiting growth and metastasis of melanomaBURNHAM INST MEDICAL RESEARCH·Filed 2008·Granted Aug 17, 2010·16 cites·12 claims
- 0587US12144806B2Quinolines that modulate SERCA and their use for treating diseaseNEURODON CORP·Filed 2024·Granted Nov 19, 2024·0 cites·5 claims
- 0687US11827626B2Quinolines that modulate SERCA and their use for treating diseaseNEURODON CORP·Filed 2021·Granted Nov 28, 2023·1 cites·8 claims
- 0786US2025248990A1Quinolines that modulate serca and their use for treating diseaseNEURODON CORP·Filed 2024·Application pending·0 cites
- 0885US11992487B2Quinolines that modulate SERCA and their use for treating diseaseNEURODON CORP·Filed 2023·Granted May 28, 2024·0 cites·1 claims
- 0984US10772881B2Quinolines that modulate SERCA and their use for treating diseaseDAHL RUSSELL·Filed 2019·Granted Sep 15, 2020·5 cites·8 claims
- 1082US7919617B2Cytokine inhibitorsITHERX PHARMACEUTICALS INC·Filed 2009·Granted Apr 5, 2011·4 cites·3 claims
- 1182US7897599B2Cytokine inhibitorsITHERX PHARMACEUTICALS INC·Filed 2009·Granted Mar 1, 2011·4 cites·3 claims
- 1282US6924284B2PARP inhibitorsDELTAGEN RES LABS LLC·Filed 2002·Granted Aug 2, 2005·42 cites·55 claims
- 1373US9884826B2Sulfonamide compounds and uses as TNAP inhibitorsSANFORD BURNHAM MED RES INST·Filed 2016·Granted Feb 6, 2018·1 cites·17 claims
- 1471US7749999B2Alpha-ketoamides and derivatives thereofITHERX PHARMACEUTICALS INC·Filed 2004·Granted Jul 6, 2010·5 cites·35 claims
- 1570US9458147B2Sulfonamide compounds and uses as TNAP inhibitorsSANFORD-BURNHAM MEDICAL RES INST·Filed 2013·Granted Oct 4, 2016·1 cites·14 claims
- 1665US9845320B2Benzothiazole or benzoxazole compounds as sumo activatorsICAHN SCHOOL MED MOUNT SINAI·Filed 2013·Granted Dec 19, 2017·1 cites·9 claims
- 1764US11220498B2Neuroprotective aminothiazolesDAHL RUSSELL·Filed 2019·Granted Jan 11, 2022·0 cites·4 claims
- 1863US2021323924A1Quinoline sulfonamides useful to treat diseaseDAHL RUSSELL·Filed 2021·Application pending·0 cites
- 1963US2025134871A1Upr modulators to treat hearing lossJACARANDA BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2063US2021269404A1Quinoline amines useful as cytoprotective agentsDAHL RUSSELL·Filed 2021·Application pending·0 cites
- 2160US2020347038A1Quinolines that modulate serca and their use for treating diseaseDAHL RUSSELL·Filed 2020·Application pending·0 cites
- 2259US2019337899A1Quinoline sulfonamides useful to treat diseaseDAHL RUSSELL·Filed 2019·Application pending·0 cites
- 2359US2020039939A1Quinoline amines useful as cytoprotective agentsDAHL RUSSELL·Filed 2019·Application pending·0 cites
- 2457US10370333B2Sulfonamide compounds and uses as TNAP inhibitorsSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST·Filed 2018·Granted Aug 6, 2019·0 cites·17 claims
- 2556US10793558B2Quinoline oxadiazoles as cytoprotective agentsDAHL RUSSELL·Filed 2019·Granted Oct 6, 2020·0 cites·4 claims
- 2656US10383867B2Quinoline derivatives and their use for treating endoplasmic reticulum stress-related diseases and disordersDAHL RUSSELL·Filed 2016·Granted Aug 20, 2019·0 cites·1 claims
- 2755US10730839B2Quinolines as cytoprotective agentsDAHL RUSSELL·Filed 2019·Granted Aug 4, 2020·0 cites·8 claims
- 2855US10730843B1Quinoxalines useful as cytoprotective agentsDAHL RUSSELL·Filed 2019·Granted Aug 4, 2020·0 cites·10 claims
- 2954US11213701B2Neuroprotective quinoline sulfonamidesDAHL RUSSELL·Filed 2019·Granted Jan 4, 2022·0 cites·4 claims
- 3054US10011578B2Compounds for stabilizing ryanodine receptors from aberrant levels of calcium releaseUNIV ROSALIND FRANKLIN MEDICINE & SCIENCE·Filed 2017·Granted Jul 3, 2018·0 cites·5 claims
- 3152US10800766B2Quinoline alkenes as cytoprotective agentsDAHL RUSSELL·Filed 2019·Granted Oct 13, 2020·0 cites·6 claims
- 3250US2010273797A1Alpha-ketoamides and derivatives thereofITHERX PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 3349US10099993B2Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereofSANFORD BURNHAM MED RES INST·Filed 2015·Granted Oct 16, 2018·0 cites·24 claims
- 3449US9725429B2Furanyl-imine and thiofuranyl-imine compounds for stabilizing ryanodine receptors from aberrant levels of calcium releaseUNIV ROSALIND FRANKLIN MEDICINE & SCIENCE·Filed 2015·Granted Aug 8, 2017·0 cites·6 claims
- 3549US7888355B2Compositions and methods for inhibiting growth and metastasis of melanomaBURNHAM INST MEDICAL RESEARCH·Filed 2010·Granted Feb 15, 2011·0 cites·5 claims
- 3647US2011166216A1Compositions and Methods for Inhibiting Growth and Metastasis of MelanomaBURNHAM INST MEDICAL RESEARCH·Filed 2011·Application pending·0 cites
- 3746US10501453B2Benzothiazole or benzoxazole compounds as SUMO activatorsICAHN SCHOOL MED MOUNT SINAI·Filed 2017·Granted Dec 10, 2019·0 cites·16 claims
- 3846US2020190077A1Neuroprotective hydrazidesDAHL RUSSELL·Filed 2019·Application pending·0 cites
- 3940US9102645B2Compounds for stabilizing ryanodine receptors from aberrant levels of calcium releaseUNIV ROSALIND FRANKLIN MEDICINE & SCIENCE·Filed 2014·Granted Aug 11, 2015·0 cites·3 claims
- 4038US2007232648A1Modulators of the glucocorticoid receptor and methodBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 4134US2011257233A1Benzoisothiazolones as inhibitors of phosphomannose isomeraseSANFORD BURNHAM MED RES INST·Filed 2011·Application pending·0 cites
- 4234US2017281611A1Quinolines and their use for treating endoplasmic reticulum stress-caused diseasesEIGER BIOPHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →